MSD IrelandMick PhelanBusiness Unit Director

Known as MSD worldwide except in the US and Canada where we are Merck

A global healthcare leader working to help the world be well The world’s No. 2 healthcare company that operates in

140 countries We develop and deliver prescription medicines, vaccines,

biologic therapies, and consumer care and animal health products

We are committed to increasing access to healthcare through far-reaching policies, programmes and partnerships to help people around the world lead healthier lives

MSD across the Globe

We employ over 2,000 people at sites in Dublin, Carlow, Cork, Tipperary and Wicklow.

We have invested over €2.2bn in Ireland over the last five decades

In 2011 we spent in excess of €400 million on goods and services in Ireland, thus supporting many other businesses and jobs in the Irish economy

In 2012 we contributed €2.3m in support of medical education for healthcare professionals, for local Irish charities, community and patient groups, and in our work towards environmental sustainability

MSD in Ireland

Irish Sites

We manufacture or package many of our leading products for the world market in Ireland – 12 of our global top 20 products are manufactured in Ireland

Our Irish sites are renowned for their capability to rapidly introduce new products (and additional volumes of existing products) at minimal additional capital cost, ensuring supply for new product launches / expanding market opportunities

Our Carlow site is a state-of-the-art vaccines and biologics facility, with ambitious growth plans for its future. It is MSD’s first vaccines facility to be built outside of the US

Our Ballydine site currently supports worldwide revenues of approx. €8bn and focuses on new product R&D commercialisation

Our Manufacturing Presence

Our Areas of Focus

MSD Partnership in Hospitals Longstanding contributions to Education, Patient Programs,

Disease Management, Clinical Staff Support, Health Care Technology

Therapeutic focus include Rheumatology, Gastroenterology, Cardiology, Diabetes, Microbiology, Critical Care and Surgery

We are focused on understanding the changing environment: e.g., emergence of Hospital Groups, MFTP and other planned Health Care Reforms.

MSD is evolving to reflect these changes and to ensure that we remain an effective partner for you through the change.

MSD is Evolving

10% reduction through voluntary redundancies Dec 2013

Refocusing efforts to growth areas and new product launches (e.g., Infectious Disease, Oncology)

Resources increased in Market Access, Account Management and Medical Affairs

Account Management aligned with Hospital Group structure

Hospital Account Managers Ger Bowens

Niamh McEvoy

Anne Martina Mulligan

• Interact with Hospital Group Management• Understand the Group, its priorities and ID mutually beneficial

partnership opportunities• Commercial Negotiations

• Interact with Hospital Group Management• Understand the Group, its priorities and ID mutually beneficial

partnership opportunities• Commercial Negotiations

MSD Hospital Group Partnership Approach

 

Partnership opportunities close to our current and pipeline therapeutic areas Opportunities may be MSD alone or in collaboration with other pharmacy/industry partnersFocus, at least initially on smaller, short term, patient outcome focused and measurable initiativesLarge partnership groups with broad, long term, difficult to measure objectives are less attractive.We are committed to MSD’s ethical and compliance standards and requirements. When working with industry partners, recognise that compliance requirements will differ by companyPartnership engagements may identify potential business development opportunities

Thank You www.msd.ie